Information Provided By:
Fly News Breaks for June 23, 2017
ESPR
Jun 23, 2017 | 07:33 EDT
Deutsche Bank analyst Andrew Peters started Esperion with a Buy rating and $48 price target, as he believes its data suggest a clear role for bempedoic acid that is underappreciated.
News For ESPR From the Last 2 Days
ESPR
Mar 28, 2024 | 10:59 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here
ESPR
Mar 27, 2024 | 10:47 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here